Invention Grant
- Patent Title: Single nucleotide polymorphism in HLA-B*15:02 and use thereof
-
Application No.: US15933325Application Date: 2018-03-22
-
Publication No.: US10683548B2Publication Date: 2020-06-16
- Inventor: Hua Fang , Xiequn Xu , Tanya Moreno , Matthew Dedek , Kulvi Kaur
- Applicant: Millennium Health, LLC
- Applicant Address: US CA San Diego
- Assignee: Millennium Health, LLC
- Current Assignee: Millennium Health, LLC
- Current Assignee Address: US CA San Diego
- Agency: Greenberg Traurig, LLP
- Agent Fang Xie
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; A61K31/55 ; C12Q1/6883
Abstract:
Disclosed herein is a novel single nucleotide polymorphism (SNP) in HLA-B*15:02 that can be used as a biomarker for carbamazepine-induced severe adverse skin reactions in Asians. Also provided herein are methods and reagents for assessing the specific SNP, and applying the SNP in predicting an increased risk of carbamazepine-induced severe adverse skin reactions.
Public/Granted literature
- US20180216190A1 Single Nucleotide Polymorphism in HLA-B*15:02 and Use Thereof Public/Granted day:2018-08-02
Information query
